Updating results
821 results for diabetes Sort: Relevance | Date
Evidence-based recommendations on preventing type 2 diabetes for adults at high risk of diabetes
Evidence-based statements to deliver quality improvements in managing diabetes and its complications in pregnancy
Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart
Evidence-based statements to deliver quality improvements in managing diabetes in adults
Everything NICE has said on preventing type 2 diabetes in an interactive flowchart
Everything NICE has said on managing diabetes and its complications before, during and after pregnancy in an interactive flowchart
Everything NICE has said on managing type 1 and 2 diabetes in children, young people and adults in an interactive flowchart
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
Evidence-based recommendations on the care and management of type 2 diabetes in adults
Evidence-based recommendations on the diagnosis and management of type 1 diabetes in adults
Evidence-based statements to deliver quality improvements in diagnosing and managing diabetes in children and young people
Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart
Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart
Evidence-based recommendations on managing diabetes in pregnancy and its complications from pre-conception until after the birth
Evidence-based recommendations on preventing type 2 diabetes among populations and communities of adults who are at high risk
Evidence-based recommendations on implanting a duodenal–jejunal bypass liner for managing type 2 diabetes
Evidence-based recommendations on allogeneic pancreatic islet cell transplantation for treating type 1 diabetes mellitus
Evidence-based recommendations on the diagnosis and management of type 1 and type 2 diabetes in children and young people
Evidence-based recommendations on continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
Evidence-based recommendations on dapagliflozin (Forxiga) in combination therapy for treating type 2 diabetes in adults
Evidence-based recommendations on empagliflozin (Jardiance) in combination therapy for treating type 2 diabetes
Evidence-based recommendations on canagliflozin (Invokana) in combination therapy for treating type 2 diabetes
Evidence-based recommendations on canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance) for treating type 2 diabetes in adults
Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults
Summary of the evidence on dulaglutide for treating type 2 diabetes to inform local NHS planning and decision-making
Evidence-based recommendations on the MiniMed Paradigm Veo and Vibe and G4 PLATINUM CGM sensor-augmented pump therapy systems for type 1 diabetes
Summary of the evidence on insulin degludec for treating type 1 diabetes to inform local NHS planning and decision-making
Summary of the evidence on insulin degludec for treating type 2 diabetes to inform local NHS planning and decision-making
Summary of the evidence on lixisenatide (glucagon-like peptide-1 [GLP-1] mimetic) for treating type 2 diabetes to inform local NHS planning and decision-making
Summary of the evidence on alogliptin (a dipeptidyl peptidase-4 [DPP-4] inhibitor) for type 2 diabetes to inform local NHS planning and decision-making
Summary of the evidence on insulin degludec/liraglutide (Xultophy) for treating type 2 diabetes to inform local NHS planning and decision-making
Summary of the evidence on insulin glargine biosimilar (Abasaglar) for type 1 and type 2 diabetes mellitus to inform local NHS planning and decision-making
Advice on the MiniMed 640G system with SmartGuard for managing blood glucose levels in type 1 diabetes to aid local decision-making
Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 1 diabetes mellitus to inform local NHS planning and decision-making
Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 2 diabetes mellitus to inform local NHS planning and decision-making
Evidence-based recommendations on the prevention and management of foot problems in children, young people and adults with diabetes.
In development [GID-TAG244] Expected publication date: TBC
Admission rates for people with diabetes due to complications associated with diabetes Subject(s): Diabetes Date of publication: 01 August 2016 NICE...
Proportion of adults with diabetes with a HES recording of National Diabetes Audit complications Subject(s): Diabetes NICE identity code: CCG16 Key...
KTT12 Type 2 diabetes mellitus: medicines optimisation priorities Options for local implementation The NICE guideline on type 2 diabetes in adults:...
ThinkGlucose is designed to improve the care of people with diabetes when they are admitted to hospital.
Advice on the use of FreeStyle Libre for monitoring glucose levels in diabetes to aid local decision-making
Admission rates due to diabetic ketoacidosis in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016 NICE identity code:...
Admission rates due to stroke in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016 NICE identity code: CCG62 Key...
Admissions rates due to myocardial infarction in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016 NICE identity code:...
Admissions rates for renal replacement therapy in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016 NICE identity code:...
Admission rates due to heart failure in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016 NICE identity code: CCG61 Key...
Admissions rates due to angina in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016 NICE identity code: CCG59 Key...
The contractor establishes and maintains a register of all patients aged 17 or over with diabetes mellitus, which specifies the type of diabetes...